GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.71 Cr | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.71 Cr |
| Mar2024 | ₹3.73 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹4.00 Cr |
| Mar2021 | ₹3.88 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.71 Cr | 26.36 | |
| Mar2024 | ₹3.73 Cr | -7.56 | |
| Mar2023 | ₹4.03 Cr | 0.98 | |
| Mar2022 | ₹4.00 Cr | 3.10 | |
| Mar2021 | ₹3.88 Cr | - | |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,020.5 Cr | 6.1% | 12.5% | 6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 6.1% |
12.5% |
6.9% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses